Syneron to Acquire Ultrashape Ltd.

See more in:

Syneron Announces New Ground Breaking evolastin™ Procedure

Syneron Announces New Ground Breaking evolastin™ Procedure

Syneron announces the launch of evolastin™ – the industry’s first energy-based dermal
remodeling procedure that delivers controlled radio frequency energy directly to the deep
dermis to stimulate the skin’s natural production of collagen, elastin and hyaluronic acid
in a single treatment.

Read More HERE

 

 

 

 

 

 

See more in:

Syneron to Participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Syneron to Participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Syneron announced today that Asaf Alperovitz, Chief Financial Officer, is scheduled to participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco.

Read More

 

 

See more in:

Syneron Beauty Inc. Launches Revolutionary New Skincare Product, Website

See more in:

ePrime featured on as one of "5 Ways to Look Great By Thanksgiving" by RealSelf.com Blog

ePrime featured on as one of "5 Ways to Look Great By Thanksgiving" by RealSelf.com Blog

RealSelf.com "is a community dedicated to helping people make the right health & beauty choices." It is one of the strongest patient-reviewes sites in the US.

See more in:

Dr. Shimon Eckhouse Interview in Prime Magazine

See more in:

VelaShape II New Eight-Hour Covers and eTwo's Sublative iD Tips

See more in:

Syneron's New ePrime Device Featured on The Doctors Show as the Latest Super Age Eraser

ePrime's single treatment sparks revolutionary new wave for energy-based facial aesthetic procedures.

Syneron's featured a live demonstration of their latest technology, ePrime, on the October 27, 2011 segment of The Doctors. The audience and viewers of The Doctors witnessed first-hand the ePrime procedure and the immediate post treatment results.

Read more

See more in:

Syneron to Participate in Three Upcoming Investor Conferences

Syneron to Participate in Three Upcoming Investor Conferences:

Brean Murray, Carret & Co. Life Sciences Summit
Date: Monday, November 14, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Lazard Capital Markets 8th Annual Healthcare Conference
Date and Time: 2:30 pm ET on Wednesday, November 16, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Leerink Swann Healthcare Management Access Day
Date: Monday, November 21, 2011
Syneron Participant: Louis P. Scafuri, Chief Executive Officer 

See more in:

Syneron Sets New Facial Rejuvenation Standard

See more in:

12345678next ›last »

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron®'s signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron® products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.